Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Granules India Ltd.
NSE: GRANULES
|
BSE: 532482
|
ISIN: INE101D01020
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
601.9500
-5.40
(
-0.89
%)
NSE
Jan 09, 2026
15:31 PM
New 52W High in past week
Volume:
952.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Granules India Ltd.
13 Jun 2023
US FDA Approval
601.95
-0.89%
GRANULES INDIA
Buy:
Granules India Ltd.
by
Geojit BNP Paribas
Target: 342
Recommendation
Target
Geojit BNP Paribas
Number of FII/FPI investors decreased from 199 to 189 in Sep 2025 qtr
More from Granules India Ltd.
Recommended
Five Interesting Stocks Today - January 9, 2026
The Baseline |
09 Jan 2026, 05:30PM
Market closes lower, dragged down by foreign investor outflows and rising crude prices
Trendlyne Marketwatch |
09 Jan 2026, 03:55PM
Granules: Will the record-breaking numbers sustain for this API pharmaceutical company?
|
30 Oct 2020